Complicaciones letales y linfocitopenia CD3+Periférica pretratamiento en linfomas No Hodgkin. Reporte de 5 casos / Lethal complications and peripheral lymphocytopenia CD3+ pretreatment in Non-Hodgkin lymphoma. A report of five cases
Rev. cuba. oncol
;
17(1): 54-58, ene.-abr. 2001. tab
Article
in Spanish
| LILACS
| ID: lil-331415
RESUMO
Multiple immune impairments in Non-Hodgkin patients are associated with their clinical development. The aim of this study was to describe the composition of peripheral T cell subpopulations before treatment in patients who died from infection or serious radiogenic complication together with tumoral activity. During a follow-up period of 8.18 years as an average; 5 cases affected by any of these complications which were not controlled by the treated were recorded. Lymphocytopenia CD3+ was the only common datum observed in the analysis covering variables of recognized prognostic death value. It was concluded that the low CD3+ count is a comorbid prognostic factor in Non-Hodgkin lymphoma that should not be ignored because of its fatal consequences
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Prognosis
/
T-Lymphocytes
/
Immunosuppression Therapy
/
Immune Tolerance
/
Lymphopenia
Type of study:
Prognostic study
Limits:
Humans
Language:
Spanish
Journal:
Rev. cuba. oncol
Journal subject:
Neoplasms
Year:
2001
Type:
Article
Affiliation country:
Cuba
Institution/Affiliation country:
Facultad de Medicina Manuel Fajardo de la Universidad de La Habana/CU
Similar
MEDLINE
...
LILACS
LIS